Octapharma AG

Biotechnology ResearchCommunity of Madrid, Spain11-50 Employees

Octapharma AG operates as a biotechnology company focused on developing and producing human proteins derived from plasma and cell lines. It is based in Madrid, Spain, and participates in the biotechnology research sector. The company has introduced products addressing surgical blood loss, including Pronativ, a four-factor prothrombin complex concentrate launched in 2019. In 2021 it partnered with Akron Biotech to manufacture virally inactivated human AB serum for the cell therapy market, using Octaplas.

Within the broader biotech landscape, Octapharma has been described as one of the largest manufacturers of human proteins. The organization operates with a relatively small workforce. Its public presence is centered on its website, octapharma.com, and its activities span collaborations with other firms to support cell therapy manufacturing and related medical applications.

Sign up for free to view info

Email Format Employee directory